Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 6, 2004, Pages 1095-1097

  Uh, Young ^a   Shin, Dong Hoon ^b   Hwang, Gyu Yel ^a   Lee, Mi Kyung ^a   Yoon, Kap Jun ^a   Kim, Hyo Youl ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Hallym College   (South Korea)

Author keywords

haemolytic streptococci; Erm(B); Erythromycin resistance; Mef(A); MLSB phenotype

Indexed keywords

CEFTRIAXONE; CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B; PENICILLIN G; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; BLOOD CULTURE; CONTROLLED STUDY; KOREA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; STREPTOCOCCUS BOVIS; TEACHING HOSPITAL;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GENES, BACTERIAL; GENOTYPE; HUMANS; KOREA; MACROLIDES; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STREPTOCOCCAL INFECTIONS; VIRIDANS STREPTOCOCCI;

EID: 3042681759     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh219     Document Type: Article

References (8)

1. Diekema, D. J., Beach, M. L., Pfaller, M. A. et al. (2001). Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America. Clinical Microbiology and Infection 7, 152-7.
2. National Committee for Clinical Laboratory Standards. (2003). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Sixth Edition: Approved Standard M7-A6. NCCLS, Wayne, PA, USA.
3. National Committee for Clinical Laboratory Standards. (2003). Performance Standards for Antimicrobial Susceptibility Testing - Thirteenth Informational Supplement M100-S13. NCCLS, Wayne, PA, USA.
4. Kataja, J., Huovinen, P., Skurnik, M. et al. (1999). Erythromycin resistance genes in group A streptococci in Finland. Antimicrobial Agents and Chemotherapy 43, 48-52.
5. Sutcliffe, J., Grebe, T., Tait-Kamradt, A. et al. (1996). Detection of erythromycin-resistant determinants by PCR. Antimicrobial Agents and Chemotherapy 40, 2562-6.
6. Doern, G. V., Ferraro, M. J., Brueggemann, A. B. et al. (1996). Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrobial Agents and Chemotherapy 40, 891-4.
7. Teng, L. J., Hsueh, P. R., Chen, Y. C. et al. (1998). Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. Journal of Antimicrobial Chemotherapy 41, 621-7.
8. Ioannidou, S., Tassios, P. T., Kotsovili-Tseleni, A. et al. (2001). Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children. International Journal of Antimicrobial Agents 17, 195-201.